Home » Altair Therapeutics Shut Down After Mid-Stage Asthma Study Fails
Altair Therapeutics Shut Down After Mid-Stage Asthma Study Fails
San Diego-based Altair Therapeutics, a spinoff from Isis Pharmaceuticals, has shut down operations after the startup’s only drug candidate failed in a mid-stage clinical trial against asthma.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May